image
Financial Services - Insurance - Life - NASDAQ - US
$ 5.22
-0.978 %
$ 511 M
Market Cap
-18.74
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jul, 22, 2025.

The intrinsic value of one ABL stock under the worst case scenario is HIDDEN Compared to the current market price of 5.22 USD, Abacus Life, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 22, 2025.

The intrinsic value of one ABL stock under the base case scenario is HIDDEN Compared to the current market price of 5.22 USD, Abacus Life, Inc. is HIDDEN

This DCF valuation model was last updated on Jul, 22, 2025.

The intrinsic value of one ABL stock under the best case scenario is HIDDEN Compared to the current market price of 5.22 USD, Abacus Life, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ABL

image
$9.0$9.0$8.5$8.5$8.0$8.0$7.5$7.5$7.0$7.0$6.5$6.5$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5Feb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '2515 Jul15 Jul
FINANCIALS
112 M REVENUE
68.56%
-888 K OPERATING INCOME
-3.68%
-24.9 M NET INCOME
-261.84%
-209 M OPERATING CASH FLOW
-223.62%
-4.96 M INVESTING CASH FLOW
-221.06%
320 M FINANCING CASH FLOW
453.68%
44.1 M REVENUE
32.90%
21 M OPERATING INCOME
225.44%
5.4 M NET INCOME
128.40%
-61.6 M OPERATING CASH FLOW
33.62%
-3.74 M INVESTING CASH FLOW
1.28%
-22.9 M FINANCING CASH FLOW
-10.97%
Balance Sheet Abacus Life, Inc.
image
Current Assets 160 M
Cash & Short-Term Investments 132 M
Receivables 39.9 M
Other Current Assets -12.3 M
Non-Current Assets 715 M
Long-Term Investments 376 M
PP&E 5.75 M
Other Non-Current Assets 333 M
15.09 %4.56 %42.96 %38.13 %Total Assets$874.2m
Current Liabilities 62.5 M
Accounts Payable 0
Short-Term Debt 38.9 M
Other Current Liabilities 23.5 M
Non-Current Liabilities 388 M
Long-Term Debt 347 M
Other Non-Current Liabilities 41.4 M
8.64 %5.22 %76.96 %9.19 %Total Liabilities$450.9m
EFFICIENCY
Earnings Waterfall Abacus Life, Inc.
image
Revenue 112 M
Cost Of Revenue 11.4 M
Gross Profit 101 M
Operating Expenses 101 M
Operating Income -888 K
Other Expenses 24 M
Net Income -24.9 M
120m120m100m100m80m80m60m60m40m40m20m20m00(20m)(20m)(40m)(40m)112m(11m)101m(101m)(888k)(24m)(25m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
89.84% GROSS MARGIN
89.84%
-0.79% OPERATING MARGIN
-0.79%
-21.41% NET MARGIN
-21.41%
-5.65% ROE
-5.65%
-2.74% ROA
-2.74%
-0.13% ROIC
-0.13%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Abacus Life, Inc.
image
50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Net Income -24.9 M
Depreciation & Amortization 7.91 M
Capital Expenditures -805 K
Stock-Based Compensation 43.4 M
Change in Working Capital -196 M
Others 13.2
Free Cash Flow -210 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Abacus Life, Inc.
image
Wall Street analysts predict an average 1-year price target for ABL of $13.5 , with forecasts ranging from a low of $12 to a high of $15 .
ABL Lowest Price Target Wall Street Target
12 USD 129.89%
ABL Average Price Target Wall Street Target
13.5 USD 158.62%
ABL Highest Price Target Wall Street Target
15 USD 187.36%
Price
Max Price Target
Min Price Target
Average Price Target
1616141412121010886644Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Abacus Life, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
22.4 M USD 4
9-12 MONTHS
0 USD 0
Bought
1.19 M USD 3
0-3 MONTHS
0 USD 0
3-6 MONTHS
280 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. 7980. globenewswire.com - 4 days ago
Will Abacus Life, Inc. (ABL) Beat Estimates Again in Its Next Earnings Report? Abacus Life, Inc. (ABL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 5 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL NEW YORK , July 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext. prnewswire.com - 5 days ago
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman SAN FRANCISCO, July 15, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month. globenewswire.com - 1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL NEW YORK , July 12, 2025 /PRNewswire/ -- P is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 1 week ago
DXP Enterprises, Inc. Announces Amendment of ABL Revolver HOUSTON--(BUSINESS WIRE)-- #DXPE--DXP Enterprises, Inc. (NASDAQ: DXPE) today announced that on July 1, 2025, DXP Enterprises, Inc. (the “Company”) entered into an Increase Agreement (the “Increase Agreement”) by and among the Company and certain of the Company's subsidiaries as borrowers, certain other subsidiaries of the Company as guarantors, pursuant to which the aggregate commitments under the Company's existing asset-based revolving credit facility (the “ABL Facility”) were increased by $50 millio. businesswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc. - ABL NEW YORK , July 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 2 weeks ago
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month. globenewswire.com - 2 weeks ago
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report – Hagens Berman SAN FRANCISCO, July 02, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month. globenewswire.com - 2 weeks ago
Coventry Responds to Baseless Lawsuit by Abacus Global Management, Inc. FORT WASHINGTON, Pa. , July 2, 2025 /PRNewswire/ -- Coventry, the leader and creator of the secondary market for life insurance, today released the following statement: "Abacus's (NASDAQ: ABL) lawsuit is its latest misdirection and a transparent ploy designed to delay accountability and deflect attention from serious problems of Abacus's own making," said Alan Buerger, Coventry's Chairman. prnewswire.com - 2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com - 2 weeks ago
Abacus Global Management sues Coventry alleging defamation and anticompetitive conduct Abacus Global Management (NASDAQ:ABL) announced that it has filed a lawsuit against Coventry First LLC and its chairman, Alan Buerger, alleging a coordinated campaign to defame the company and damage its business through anticompetitive practices. The complaint was filed in Florida's Ninth Circuit Court. proactiveinvestors.com - 2 weeks ago
8. Profile Summary

Abacus Life, Inc. ABL

image
COUNTRY US
INDUSTRY Insurance - Life
MARKET CAP $ 511 M
Dividend Yield 0.00%
Description Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Contact 2101 Park Center Drive, Orlando, FL, 32835 https://abacuslife.com
IPO Date Sept. 14, 2020
Employees 157
Officers Stuart Little National Sales Director Mr. Matthew A. Ganovsky Co-Founder, President & Managing Partner Mr. Kevin Scott Kirby Co-Founder, President & Managing Partner Mr. Jeff Smith Vice President of Marketing Mr. Jay J. Jackson Chief Executive Officer, President & Chairman Mr. Christopher David Romaine General Counsel Mr. Todd McNealy Co-Founder, President & Director Mr. William Hugh McCauley Jr. Chief Financial Officer Mr. Robert F. Phillips Senior Vice President of Investor Relations & Corporate Affairs Krissy Lubrano Managing Director of Operations & HR